Henogen opens new biopharmaceutical clinical supply plant
The new biopharmaceutical clinical supply plant of Henogen was inaugurated today in a ceremony attended by the Wallonia Minister-President Jean-Claude Van Cauwenberghe. "These new cGMP facilities, dedicated to the mammalian cells culture, represent a total investment of 10 million Euros", said Dr Alex Bollen, CEO ; "they feature a park of 3L & 15L bioreactors used for process development purposes and a cGMP 300L bioreactor train, operated in both fed-batch and perfusion modes, able to deliver clinical-grade biologicals at a scale appropriate to the phase I to III clinical trials", he added.
This investment extends the existing know-how of Henogen 'from gene to clinical product' to the large scale production of clinical grade monoclonal antibodies and recombinant proteins made by mammalian cells, which is a very fast growing market.
These new facilities will generate additional revenues to the existing ones (forecast 2004: 7 MEUR) in order to boost the clinical development of its proprietary products e.g. a recombinant human tissue factor derivative, currently in clinical trials as well as other undisclosed programs.
Other news from the department manufacturing
These products might interest you
Biostat STR by Sartorius
Biostat STR Generation 3 Bioreactors
Engineered for Ultimate Upstream Performance
Ambr® 250 Modular by Sartorius
Mini bioreactors for cell and gene therapies with high scalability
Maximise your process development with reliable single-use vessels
Ambr® 250 HT Consumables by Sartorius
Efficient bioprocesses with single-use bioreactors
Minimise cleaning effort and maximise flexibility for cell and microbial cultures
Brooks Instrument SLA Biotech-Serie by Brooks Instrument
Control bioprocesses efficiently and precisely with flow controllers for biotechnology applications
The SLA Biotech series has been developed specifically for the requirements in bioprocesses
Flexcell Systems by Dunn
Flexcell Cell Stretching Bioreactors for Life Science Research
Used in over 1300 laboratories worldwide, and cited in over 4000 research publications
SLAMf Biotech-Serie Massendurchflussregler by Brooks Instrument
SLAMf Mass Flow Controllers Designed Specifically for Biotech (IP66 / NEMA 4X)
Special equipment for biotech process plants, suitable for splash water and high-pressure cleaning
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous